Effect of aging on the modulation of macrophage functions by neuropeptides.
The existence of a functional connection between the nervous and the immune system is supported by increasing recent evidence. In previous work we have shown that peptides from the nervous system, such as gastrin-releasing peptide (GRP), neuropeptide Y (NPY) and sulfated cholecystokinin octapeptide (CCK-8s), have modulatory effects on the immune functions in adult animals. Since the immunodepression found in aging organisms may be related to changes in the neuroimmune network, the aim of the present work was to study the changes with aging in the effect of CCK-8s, GRP and NPY on peritoneal macrophage functions (adherence to tissues, mobility, ingestion of foreign particles and superoxide anion production) from BALB/c mice of three different ages: adult (24+/-2 weeks old), mature (50+/-2 weeks old) and old (72+/-2 weeks old). The results show that the increase in adherence capacity produced by neuropeptides in cells from adult and mature animals disappears in old mice. The stimulatory effect of GRP and NPY on mobility, ingestion and superoxide production in macrophages from adult mice disappears (GRP) or changes to inhibition (NPY) in cells from old animals. The decrease of these functions caused by CCK-8s in adult or mature animals continues in old mice. These data suggest that the modulation by neuropeptides of the macrophage function changes with the age of animals.
De la Fuente
M
M
Department of Animal Physiology, Faculty of Biology, Complutense University, Madrid, Spain. mondelaf@eucmax.sim.ucm.es
Medina
S
S
Del Rio
M
M
Ferrández
M D
MD
Hernanz
A
A
D000375:Aging / Q000502:physiology*; D000818:Animals; D002448:Cell Adhesion / Q000187:drug effects; D002478:Cells, Cultured; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D019886:Gastrin-Releasing Peptide / Q000494:pharmacology*; D017737:Macrophages, Peritoneal / Q000166:cytology / Q000187:drug effects / Q000502:physiology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009478:Neuropeptide Y / Q000494:pharmacology*; D018697:Nootropic Agents / Q000494:pharmacology; D010587:Phagocytosis / Q000187:drug effects; D012844:Sincalide / Q000031:analogs & derivatives* / Q000494:pharmacology*; D013481:Superoxides / Q000378:metabolism
C090019:8-sulfocholecystokinin octapeptide; D009478:Neuropeptide Y; D018697:Nootropic Agents; D013481:Superoxides; D019886:Gastrin-Releasing Peptide; D012844:Sincalide